Skip to Main content Skip to Navigation
Journal articles

1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03161166
Contributor : Isabelle Combe <>
Submitted on : Friday, March 5, 2021 - 5:33:29 PM
Last modification on : Saturday, March 6, 2021 - 3:19:05 AM

Identifiers

Collections

Citation

R. Gerolami, P. Merle, H.Y. Lim, R.S. Finn, M. Ikeda, et al.. 1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study. Annals of Oncology, Elsevier, 2020, 31, pp.S699-S700. ⟨10.1016/j.annonc.2020.08.1126⟩. ⟨hal-03161166⟩

Share

Metrics

Record views

26